Formulation of a stable parenteral product; Clonidine Hydrochloride Injection.

@article{Kostecka1998FormulationOA,
  title={Formulation of a stable parenteral product; Clonidine Hydrochloride Injection.},
  author={D. Kostecka and Mark R. Duncan and Daniel Wagenknecht},
  journal={PDA journal of pharmaceutical science and technology},
  year={1998},
  volume={52 6},
  pages={320-5}
}
Clonidine Hydrochloride Injection (Duraclon) is a clear, colorless, preservative-free, pyrogen free, aqueous solution of clonidine hydrochloride. The indication for this product is for use as an adjunct in pain management, administered epidurally, when opiates are insufficient. The drug formulation was evaluated under both normal and stress conditions in the preformulation/formulation studies. The list of studies conducted includes a light sensitivity study, an oxygen sensitivity study, a pH… CONTINUE READING